Oil’s Iran Cliffhanger: What To Know And What To Expect
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Symbol | Exchange | Currency |
|---|
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical company. The Company is focused on developing products to address the growing need for the use of radiopharmaceuticals in oncology. It is developing targeted copper theranostics-based on its SAR Technology Platform for the treatment of cancer in children and adults. Its lead radiopharmaceutical products include SARTATE, SAR-Bombesin and SAR-bisPSMA. SARTATE targets somatostatin receptor 2 (SSTR2) expressing cancers, including neuroblastoma and neuroendocrine tumors. SAR-Bombesin targets gastrin-releasing peptide receptor (GRPr) expressing cancers, including prostate cancer and breast cancer. SAR-bisPSMA targets prostate-specific membrane antigen (PSMA) expressing cancers, including prostate cancer. Its SAR Technology platform employs a superior chelator (cage) for copper used in the diagnosis and treatment of a range of cancers. The technology can be employed for targeted cancer therapy.
| Average | 165.37 (+19,823.70% Upside) |
| High | 240.00 |
| Low | 122.10 |
| Price | 0.83 |
| No. of Analysts | 3 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Sell | Neutral |
| Technical Indicators | Strong Sell | Strong Sell | Sell | Strong Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 5.16 | 5.26 | 5.135 | +0.050 | +0.98% | 11.20M | Sydney | |||
| 109.40 | 109.77 | 108.95 | +0.570 | +0.52% | 722.36K | Sydney | |||
| 0.69 | 0.70 | 0.68 | +0.03 | +3.79% | 5.73M | Sydney | |||
| 1.595 | 1.60 | 1.59 | +0.015 | +0.95% | 419.31K | Sydney | |||
| 0.287 | 0.29 | 0.275 | +0.013 | +4.55% | 22.69M | Sydney | |||
| 14.85 | 14.94 | 14.73 | +0.35 | +2.41% | 191.71K | Sydney | |||
| 0.008 | 0.008 | 0.008 | +0.001 | +14.29% | 70.00K | Sydney | |||
| 0.031 | 0.032 | 0.03 | +0.001 | +3.33% | 7.29M | Sydney | |||
| 0.60 | 0.60 | 0.60 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 0.565 | 0.585 | 0.555 | +0.010 | +1.80% | 47.04K | Sydney | |||
| 0.08 | 0.08 | 0.08 | 0.00 | 0.00% | 57.21K | Sydney | |||
| 0.50 | 0.50 | 0.50 | 0.00 | 0.00% | 38.15K | Sydney | |||
| 7.00 | 7.00 | 7.00 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 0.425 | 0.43 | 0.42 | +0.020 | +4.94% | 256.92K | Sydney | |||
| 0.018 | 0.02 | 0.018 | -0.002 | -10.00% | 10.10K | Sydney |